E-cadherin gene methylation in lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• E-cadherin is a tumor suppressor gene crucial for epithelial cell integrity.
• Its dysregulation, including methylation, is implicated in cancer development, invasion, and metastasis.
• Understanding E-cadherin methylation's role in lung cancer is vital for diagnosis and prognosis.

Purpose of the Study:

• To quantitatively investigate the association between E-cadherin gene methylation and lung cancer (LC) risk.
• To evaluate the impact of E-cadherin gene methylation on the overall survival (OS) of LC patients through a meta-analysis.

Main Methods:

• A systematic literature search was conducted on electronic databases up to September 30, 2013.
• Meta-analysis techniques were employed using pooled odds ratios (OR) for risk and hazard ratios (HR) for survival.
• Seventeen studies involving 983 LC cases and 669 controls were included.

Main Results:

• Hypermethylation of E-cadherin was significantly more frequent in LC tissues compared to normal controls (OR = 4.11, P < 0.001).
• Higher methylation frequencies were observed in Asian populations.
• E-cadherin hypermethylation was associated with significantly better OS in LC patients (HR = 0.47).

Conclusions:

• E-cadherin gene promoter methylation is associated with an increased risk of lung cancer, especially in Asian populations.
• Methylated E-cadherin is a predictive marker for longer survival in lung cancer patients.
• Further large-scale studies are warranted to validate these findings.